MedTrace Logo

Programme of Acromegaly Screening in Patients With Associated Somatic Disorders

NCT02020967 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 367

Last updated 2021-05-26

Study results available
· View outcomes & findings →

Summary

The primary objective of the protocol is to define percentage of patients with acromegaly in relation to the total number of screened patients with confirmed clinically significant set of associated somatic disorders with the help of laboratory (Insulin-like Growth Factor I, Growth Hormone, Oral Glucose-Tolerance Test \[IGF-1, GH, OGTT\]) and instrumental examination methods (Magnetic Resonance Imaging \[MRI\]).

Conditions

Interventions

OTHER

Non-interventional cross-sectional survey

This is a survey which does not involve any intervention into routine clinical practice, including the use of any investigational therapy or special examination methods.

Sponsors & Collaborators

Principal Investigators

  • Ipsen Medical Director · Ipsen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-05
Primary Completion
2015-09-15
Completion
2015-09-15

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02020967 on ClinicalTrials.gov